Roche announces positive results for Actemra in phase III study

VIENNA (Reuters) - Swiss drugmaker Roche said on Sunday its rheumatoid arthritis medication Actemra for giant cell arteritis showed to be superior to steroids alone in maintaining steroid-free remission in a Phase III study.